The Food and Drug Administration (FDA) has approved Restasis for treating chronic dry eye in adults and children ages 16 years and older. It’s available in single-use vials and a multiuse bottle.
Waste, cost, and "common sense" continue to rationalize healthcare providers' use of single-use vials of injectable medications for more than 1 patient. Following publication of Single-Use Vials: Cost ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback